Used primarily in pharmaceutical research, this compound is investigated for its potential as a central nervous system (CNS) agent. It may interact with neurotransmitter systems, making it a candidate for developing treatments for neurological disorders such as depression, anxiety, or schizophrenia. Its spirocyclic structure is of particular interest in medicinal chemistry for designing novel therapeutic molecules with enhanced selectivity and efficacy. Additionally, it serves as a key intermediate in the synthesis of more complex bioactive compounds. Researchers also explore its potential in modulating receptor activity, which could lead to advancements in psychopharmacology.